Home

WERNER CAUTREELS

CIK 1237419 · Chief Executive Officer · last filed 2026-07-15

WERNER CAUTREELS is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for TRAW, was dated Jul 15, 2026. Across all open-market trades the lifetime net is +$186.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $56.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.0K

Companies

3

Total Filings

12

Lifetime Open-Market Net

$186.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRAW Director 109,222 $0.51 $56.0K $0 8 2026-07-15
Cartesian Therapeutics, Inc. (SELB) Delisted President and CEO 321,203 $0.88 $283.0K $186.2K 3 2017-11-14
MCRB Director — $4.80 — $0 1 2015-06-29

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-15 TRAW Grant (A) — $0 EDGAR
2026-03-10 TRAW Grant (A) — $0 EDGAR
2025-12-16 TRAW Grant (A) +4,874 $0 EDGAR
2025-10-15 TRAW Grant (A) — $0 EDGAR
2025-06-23 TRAW Grant (A) — $0 EDGAR
2025-02-19 TRAW Exer (M) +96,348 $963 EDGAR
2025-01-27 TRAW Buy (P) — $0 EDGAR
2024-04-03 TRAW Grant (A) +200,000 $0 EDGAR
2017-11-14 Cartesian Therapeutics, Inc. (SELB) Delisted Buy (P) +20,000 $186.2K EDGAR
2017-07-11 Cartesian Therapeutics, Inc. (SELB) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.